Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00949819

Active Surveillance for Cancer of the Prostate (ASCaP)

The UCLA ASCAP Project is an Observational, Longitudinal, and Open-ended Study Aimed at Establishing a Structured Program of Non-interventional Follow-up for Localized Prostate Cancer.

Status
Recruiting
Phase
Study type
Observational
Enrollment
462 (estimated)
Sponsor
Jonsson Comprehensive Cancer Center · Academic / Other
Sex
Male
Age
30 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Detailed description

This protocol is not designed as a formal clinical trial, but rather an observational protocol; no treatments and no randomization are included. Longitudinally, specimens and clinical data will be collected to provide information on the following: * Imaging studies of the prostate * Rates of curative intervention * Measures of tumor recurrence/progression * Disease specific survival * Overall survival * Clinical data to track Quality of Life

Conditions

Interventions

TypeNameDescription
OTHERActive surveillanceSerial, long term data collection and active surveillance

Timeline

Start date
2009-07-04
Primary completion
2027-07-05
Completion
2028-12-01
First posted
2009-07-30
Last updated
2025-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00949819. Inclusion in this directory is not an endorsement.